Traduire
Le projet EMBOBIO reçoit le prix de l’innovation AP-HM 2022
NEOSTEM : soigner l’encéphalopathie anoxo-ischémique du nouveau-né grâce à la thérapie cellulaire
Spreading safe, cheap embolization around the world
Le CERIMED, une plate-forme d’imagerie transversale, interdisciplinaire et fédératrice
R&D
Located on the Marseille-Timone Campus, CERIMED is an innovative multidisciplinary working environment opened to academics and SME for the development and validation of novel medical imaging techniques and protocols.
Services
CERIMED offers its equipments and knowledge in the form of a range of service offers for academics and industries. Each CERIMED department may contribute to development and validation of your innovative medical imaging techniques and protocols.
Training
Implement a transversal way of learning and training, meeting the various concerned disciplines (physics, biology, medicine, radiopharmacy, ...) and the industry, but also offer a theoretical and practical training to the medical imaging techniques.
Recent Posts
-
Symposium’23 Program
“Innovative drugs & health products,
imaging & theranostics agents –
cell & gene biotherapies”, March 17, 2023, 13:30 - 3e matinée Carnot Star “9-12 Recherche-Industrie” dédiée à l’Imagerie, 17 Mars 2023, 8h30
- FairEmbo en Afrique : “Ce médecin marseillais sauve des femmes avec des bouts de ficelle”
- Webinar: Discover Radiotheranostics in Nuclear Medicine (15 Sept. 2022)
- Le projet EmboBio, développé au CERIMED, a reçu le prix de l’innovation AP-HM 2022
Dernières Publications (5/343)
- Tolboom, N, Verger, A, Albert, NL, Fraioli, F, Guedj, E, Traub-Weidinger, T et al.. Theranostics in Neurooncology: Heading Toward New Horizons. J Nucl Med. 2023; :. doi: 10.2967/jnumed.123.266205. PubMed PMID:38071569 .
- Bobot, M. [Cognitive impairment and the blood-brain barrier in chronic kidney disease: role of the uremic toxins]. Nephrol Ther. 2023;19 (7):1-9. doi: 10.1684/ndt.2023.51. PubMed PMID:38059844 .
- Boucher, A, Delabie, J, Lussey-Lepoutre, C, Haissaguerre, M, Ouvrard, E, Lavinia, V et al.. Performance of [18F]fluorocholine PET/CT in MEN1-related primary hyperparathyroidism before initial surgery or for persistent/recurrent disease. Eur J Nucl Med Mol Imaging. 2023; :. doi: 10.1007/s00259-023-06537-1. PubMed PMID:38057652 .
- Botsford, A, Tradi, F, Loubet, A, Tantawi, S, Soulez, G, Giroux, MF et al.. Transarterial embolization of simple pulmonary arteriovenous malformations: Long-term outcomes of 0.018-inch coils versus vascular plugs. J Vasc Interv Radiol. 2023; :. doi: 10.1016/j.jvir.2023.11.018. PubMed PMID:38013007 .
- Jin, SO, Mérida, I, Stavropoulos, I, Elwes, RDC, Lam, T, Guedj, E et al.. Characterisation of a novel [18F]FDG brain PET database and combination with a second database for optimising detection of focal abnormalities, using focal cortical dysplasia as an example. EJNMMI Res. 2023;13 (1):98. doi: 10.1186/s13550-023-01023-z. PubMed PMID:37964137 PubMed Central PMC10645721.